Guard Therapeutics announced today that it has reached another key milestone in its ongoing clinical development program. Two-thirds of the approximately 160 planned patients have now been enrolled in ...
When the plasma inside a fusion system starts to misbehave, it needs to be quickly cooled to prevent damage to the device.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback